Research indicates that m6A regulators like METTL3, METTL14, and YTHDF1 are overexpressed in cervical tumors compared to normal tissues, with elevated METTL3 and YTHDF1 levels linked to poorer prognosis [126]. The gene discussed is METTL3; the disease is uterine cervix neoplasm.